Weiss Asset Management’s ANI Pharmaceuticals ANIP Stock Holding History

Weiss Asset Management’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-76,511	Closed	-$4.87M	–	604
2024 Q2	$4.87M	Buy	+76,511	New	+$4.97M	0.18%	110
2019 Q3	–	Sell	-47,054	Closed	-$3.87M	–	383
2019 Q2	$3.87M	Sell	47,054 -32,517	-41%	-$2.31M	0.23%	80
2019 Q1	$5.61M	Sell	79,571 -28,200	-26%	-$1.66M	0.44%	57
2018 Q4	$4.85M	Buy	107,771 +75,206	+231%	+$3.94M	0.34%	67
2018 Q3	$1.84M	Buy	+32,565	New	+$1.99M	0.14%	88
2018 Q1	–	Sell	-11,639	Closed	-$750K	–	232
2017 Q4	$750K	Sell	11,639 -143,450	-92%	-$8.92M	0.07%	94
2017 Q3	$8.14M	Buy	155,089 +111,493	+256%	+$5.32M	0.9%	27
2017 Q2	$2.04M	Buy	+43,596	New	+$2.1M	0.21%	43

Other funds holding ANIP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

GACM

Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Weiss Asset Management's ANIP Position: Q3 2024 in Review

Weiss Asset Management sold out of ANI Pharmaceuticals (ANIP) in Q3 2024, closing a stake of 76,511 shares — an estimated $4.87M sold.

Weiss Asset Management first reported a position in ANIP in Q2 2017 and held it in 8 quarters. The position peaked at $8.14M in Q3 2017. 208 funds tracked by Wall St. Rank hold ANIP as of Q3 2024.

Weiss Asset Management reported no remaining ANI Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
Weiss Asset Management sold 76,511 ANI Pharmaceuticals shares in Q3 2024, an estimated $4.87M.
Weiss Asset Management first reported a position in ANI Pharmaceuticals in Q2 2017 and held it in 8 quarters.
Weiss Asset Management's ANI Pharmaceuticals position peaked at $8.14M in Q3 2017.
208 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2024.

Based on Weiss Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.